» Articles » PMID: 32436932

MiRactDB Characterizes MiRNA-gene Relation Switch Between Normal and Cancer Tissues Across Pan-cancer

Overview
Journal Brief Bioinform
Specialty Biology
Date 2020 May 22
PMID 32436932
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

It has been increasingly accepted that microRNA (miRNA) can both activate and suppress gene expression, directly or indirectly, under particular circumstances. Yet, a systematic study on the switch in their interaction pattern between activation and suppression and between normal and cancer conditions based on multi-omics evidences is not available. We built miRactDB, a database for miRNA-gene interaction, at https://ccsm.uth.edu/miRactDB, to provide a versatile resource and platform for annotation and interpretation of miRNA-gene relations. We conducted a comprehensive investigation on miRNA-gene interactions and their biological implications across tissue types in both tumour and normal conditions, based on TCGA, CCLE and GTEx databases. We particularly explored the genetic and epigenetic mechanisms potentially contributing to the positive correlation, including identification of miRNA binding sites in the gene coding sequence (CDS) and promoter regions of partner genes. Integrative analysis based on this resource revealed that top-ranked genes derived from TCGA tumour and adjacent normal samples share an overwhelming part of biological processes, which are quite different than those from CCLE and GTEx. The most active miRNAs predicted to target CDS and promoter regions are largely overlapped. These findings corroborate that adjacent normal tissues might have undergone significant molecular transformations towards oncogenesis before phenotypic and histological change; and there probably exists a small yet critical set of miRNAs that profoundly influence various cancer hallmark processes. miRactDB provides a unique resource for the cancer and genomics communities to screen, prioritize and rationalize their candidates of miRNA-gene interactions, in both normal and cancer scenarios.

Citing Articles

ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.

Sindhoo A, Sipy S, Khan A, Selvaraj G, Alshammari A, Casida M Database (Oxford). 2023; 2023.

PMID: 37815872 PMC: 10563827. DOI: 10.1093/database/baad063.


Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway.

Wang X, Luo T, Lu S, Lu H, Zhao T, Jiang Z Heliyon. 2023; 9(4):e14816.

PMID: 37035389 PMC: 10073894. DOI: 10.1016/j.heliyon.2023.e14816.


CmirC: an integrated database of clustered miRNAs co-localized with copy number variations in cancer.

Ware A, Satyamoorthy K, Paul B Funct Integr Genomics. 2022; 22(6):1229-1241.

PMID: 36287286 PMC: 9701657. DOI: 10.1007/s10142-022-00909-w.


miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.

Wang J, Jin J, Liang Y, Zhang Y, Wu N, Fan M Front Genet. 2022; 13:978840.

PMID: 36186442 PMC: 9516396. DOI: 10.3389/fgene.2022.978840.


The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets.

Deng Z, Chen G, Dai F, Liu S, Yang D, Bao A PLoS One. 2022; 17(4):e0267108.

PMID: 35486636 PMC: 9053781. DOI: 10.1371/journal.pone.0267108.


References
1.
Cursons J, Pillman K, Scheer K, Gregory P, Foroutan M, Hediyeh-Zadeh S . Combinatorial Targeting by MicroRNAs Co-ordinates Post-transcriptional Control of EMT. Cell Syst. 2018; 7(1):77-91.e7. DOI: 10.1016/j.cels.2018.05.019. View

2.
Liu M, Roth A, Yu M, Morris R, Bersani F, Rivera M . The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis. Genes Dev. 2013; 27(23):2543-8. PMC: 3861668. DOI: 10.1101/gad.224170.113. View

3.
Wong N, Wang X . miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2014; 43(Database issue):D146-52. PMC: 4383922. DOI: 10.1093/nar/gku1104. View

4.
Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz Jr L, Kinzler K . Cancer genome landscapes. Science. 2013; 339(6127):1546-58. PMC: 3749880. DOI: 10.1126/science.1235122. View

5.
Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F . Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res. 2010; 70(8):3140-9. PMC: 4303586. DOI: 10.1158/0008-5472.CAN-09-4456. View